A Arancibia

561 total citations
47 papers, 453 citations indexed

About

A Arancibia is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, A Arancibia has authored 47 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 13 papers in Pediatrics, Perinatology and Child Health and 8 papers in Oncology. Recurrent topics in A Arancibia's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Pharmaceutical studies and practices (7 papers) and Analytical Methods in Pharmaceuticals (6 papers). A Arancibia is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Pharmaceutical studies and practices (7 papers) and Analytical Methods in Pharmaceuticals (6 papers). A Arancibia collaborates with scholars based in Chile, Brazil and Switzerland. A Arancibia's co-authors include Corina Gonzalez, Claudío Paulos, J. Guttmann, W. A. Ritschel, Marı́a Nella Gai, G González-Martín, Manuel E. Lladser, María I. Morasso, Pilar Caro and José H. Zagal and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacy and Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

A Arancibia

45 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Arancibia Chile 13 89 78 66 58 51 47 453
Dennis H. Giesing United States 11 52 0.6× 110 1.4× 62 0.9× 28 0.5× 28 0.5× 18 479
Kiumars Vadiei United States 16 62 0.7× 40 0.5× 118 1.8× 91 1.6× 14 0.3× 26 588
Nils‐Olov Bodin Sweden 10 86 1.0× 58 0.7× 69 1.0× 30 0.5× 81 1.6× 12 392
W. Tetzloff Germany 10 96 1.1× 39 0.5× 85 1.3× 165 2.8× 32 0.6× 13 659
J. J. Aramayona Spain 17 299 3.4× 74 0.9× 147 2.2× 41 0.7× 30 0.6× 36 657
Anna Wiela−Hojeńska Poland 12 113 1.3× 66 0.8× 72 1.1× 36 0.6× 16 0.3× 42 416
Heather A. Friedel 10 149 1.7× 145 1.9× 197 3.0× 50 0.9× 16 0.3× 11 797
A Mignot France 10 134 1.5× 57 0.7× 48 0.7× 27 0.5× 14 0.3× 27 328
Donald G. Corby United States 13 82 0.9× 23 0.3× 49 0.7× 92 1.6× 41 0.8× 30 685
Daisuke Teshima Japan 16 85 1.0× 65 0.8× 141 2.1× 45 0.8× 9 0.2× 44 539

Countries citing papers authored by A Arancibia

Since Specialization
Citations

This map shows the geographic impact of A Arancibia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Arancibia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Arancibia more than expected).

Fields of papers citing papers by A Arancibia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Arancibia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Arancibia. The network helps show where A Arancibia may publish in the future.

Co-authorship network of co-authors of A Arancibia

This figure shows the co-authorship network connecting the top 25 collaborators of A Arancibia. A scholar is included among the top collaborators of A Arancibia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Arancibia. A Arancibia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Májer, István, et al.. (2018). PSY63 - COST BY OUTCOMES ANALYSIS OF NOVEL TRIPLE-COMBINATION THERAPIES FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA IN BRAZIL. Value in Health. 21. S446–S446. 1 indexed citations
4.
Gai, Marı́a Nella, Edda Costa, & A Arancibia. (2009). Bioavailability of a controlled-release cyclobenzaprine tablet and influence of a high fat meal on bioavailability. International Journal of Clinical Pharmacology and Therapeutics. 47(4). 269–274. 1 indexed citations
5.
Arancibia, A, et al.. (2005). Pharmacokinetics of prednisolone in man during acute and chronic exposure to high altitude. International Journal of Clinical Pharmacology and Therapeutics. 43(2). 85–91. 20 indexed citations
6.
Gai, Marı́a Nella, et al.. (2005). Determination of Prednisolone and Prednisone in Plasma, Whole Blood, Urine, and Bound-to-Plasma Proteins by High-Performance Liquid Chromatography. Journal of Chromatographic Science. 43(4). 201–206. 16 indexed citations
7.
Arancibia, A, et al.. (2004). Effects of high altitude exposure on the pharmacokinetics of furosemide in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 42(6). 314–320. 18 indexed citations
8.
Arancibia, A, et al.. (2003). Pharmacokinetics of lithium in healthy volunteers after exposure to high altitude. International Journal of Clinical Pharmacology and Therapeutics. 41(5). 200–206. 28 indexed citations
9.
Gai, Marı́a Nella, et al.. (2000). Effect of three different diets on the bioavailability of a sustained release lithium carbonate matrix tablet. International Journal of Clinical Pharmacology and Therapeutics. 38(6). 320–326. 4 indexed citations
10.
Ritschel, W. A., et al.. (1998). Urinary excretion of acetazolamide in healthy volunteers aftershort- and long-term exposure to high altitude. Methods and Findings in Experimental and Clinical Pharmacology. 20(2). 133–133. 14 indexed citations
11.
Pinilla, E., et al.. (1996). Chronopharmacokinetics of theophylline administered as a controlled-release tablet.. PubMed. 34(3). 130–3. 3 indexed citations
12.
Arancibia, A. (1991). Calidad biofarmaceutica . Estudios in vitro e in vivo. 10(2). 123–133. 1 indexed citations
13.
Arancibia, A, et al.. (1988). Biopharmaceutical study of a vitamin C controlled-release formulation.. PubMed. 43(12). 387–95. 1 indexed citations
14.
González-Martín, G, et al.. (1987). Ranitidine disposition in severe hepatic cirrhosis.. PubMed. 25(3). 139–42. 7 indexed citations
15.
Arancibia, A, et al.. (1987). The effect of ultrasound on the size of liposomes.. PubMed. 55(1). 133–6. 1 indexed citations
16.
Arancibia, A, et al.. (1986). Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.. PubMed. 24(5). 240–5. 16 indexed citations
17.
González-Martín, G, et al.. (1986). Pharmacokinetics of gentamicin in children with nephrotic syndrome.. PubMed. 24(10). 555–8. 4 indexed citations
18.
Morasso, María I., et al.. (1985). In vitro and in vivo study of the substantivity of p-amino benzoic acid and two of its esters. Journal of the Society of Cosmetic Chemists. 36(5). 355–362. 5 indexed citations
19.
González-Martín, G, et al.. (1985). Pharmacokinetics of cimetidine in patients with liver disease.. PubMed. 23(7). 355–8. 4 indexed citations
20.
Arancibia, A, et al.. (1982). Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.. PubMed. 20(10). 447–53. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis H. Giesing Breakdown of academic impact, for papers by Kiumars Vadiei Breakdown of academic impact, for papers by Nils‐Olov Bodin Breakdown of academic impact, for papers by W. Tetzloff Breakdown of academic impact, for papers by J. J. Aramayona Breakdown of academic impact, for papers by Anna Wiela−Hojeńska Breakdown of academic impact, for papers by Heather A. Friedel Breakdown of academic impact, for papers by A Mignot Breakdown of academic impact, for papers by Donald G. Corby Breakdown of academic impact, for papers by Daisuke Teshima
Rankless by CCL
2026